2 completed, 1 recruiting. 2 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow I-kappa B Kinase: new trials by email Literature Review of I-kappa B Kinase trials Research Report on I-kappa B Kinase
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients IP1 control cream (Vehicle base), IP2 - 0.5% w/w FS2 - Burn Scar, Burn Wound | Phase 2 / Phase 3 | Recruiting | Birch BioMed Inc | 70 | 2027-03-01 | 2026-09-30 |
| Comparative Single-dose Bioavailability Study of Different CoQ10 Formulations Single dose intervention with Standard product (SP), Single dose intervention with Investigational product (IP1), Single dose intervention with Investigational product (IP2) - Bioavailability of Coenzyme Q10 | Not applicable | Completed | Institute of Nutrition, Slovenia (Nutris) | 30 | 2021-02-28 | 2022-12-14 |
| The Effect of Content of Barley Beta-glucans in Bread on Postprandial Blood Sugar REFERENCE: white bread - BGL0 [RP], TEST: b-glucan enriched bread - BGL2 [IP1], TEST: b-glucan enriched bread - BGL3 [IP2] - Glycemic Index | Not applicable | Completed | Institute of Nutrition, Slovenia (Nutris) | 12 | 2018-11-26 | 2019-03-19 |
Institute of Nutrition, Slovenia (Nutris) (2) · Birch BioMed Inc (1)
Slovenia (2) · Canada (1)
Carlos Camozzi, MD, PHD (1) · Igor Pravst (1) · Igor Pravst, PhD (1) · Tina Modrej Zadnikar (1)